Symbia Intevo Bold™ combines high-performance CT with advanced SPECT imaging to accommodate even the most challenging situations. For those who want more from their system, Symbia Intevo Bold offers the flexibility to take your capabilities even further with a range of unique and powerful SPECT and CT options.
- Home
- Medical Imaging
- Molecular Imaging
- SPECT/CT Scanner
- Symbia Intevo Bold

Symbia Intevo BoldMore CT for your SPECT/CT
Features & Benefits


More clarity for more patients
We re-engineered SPECT/CT bone imaging to use CT as the frame-of-reference during image reconstruction. The higher image resolution achieved from xSPECT Bone™ technology enables you to better localize and characterize disease for a more accurate representation of each patient’s condition.
As patient populations continue to age, the growing presence of metal implants and pacemakers adds complexity to imaging. iMAR, our CT metal-artifact-reduction technique, helps improve both CT and SPECT attenuation correction in these cases.2 xSPECT Bone and iMAR can easily be combined for even greater image clarity.

Dose reduction without compromise
For quick and conclusive answers to clinical questions, you need the best image for each patient. However, striking the right balance between image quality and radiation dose can be a challenge, particularly given today’s diverse patient population. Our proprietary CT image reconstruction software and hardware, SAFIRE, lets you accomplish this—quickly and easily.3

The right care at the right time
Adding reliable quantification to your clinical routine can facilitate quicker consensus and generate greater consistency across your institution. Our xSPECT Quant™ and Broad Quantification™ technologies generate highly accurate and reliable measurements to support early diagnoses and optimal therapeutic strategies for a wide array of clinical indications.
Clinical Use

xSPECT Bone sharply delineates severe osteoarthritis in the left hip joint
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

Reducing metal artifacts with iMAR may lead to more accurate quantification
Scanner: Symbia Intevo BoldTM SPECT/CT

Reducing image distortion with iMAR may improve accuracy of image interpretation
Scanner: Symbia Intevo BoldTM SPECT/CT

iMAR helps visualization of anatomical and functional findings in areas impacted by metal artifacts
Scanner: Symbia Intevo BoldTM SPECT/CT

xSPECT Quant enables quantification of tracer uptake to support therapy response assessment
Scanner: Symbia Intevo BoldTM SPECT/CT

Quantification of therapeutic dose in metastatic lesions with 177Lu PSMA
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of University Hospital of Würzburg, Würzburg, Germany.

xSPECT Quant used in 123I MIBG study to accurately evaluate uptake in suspected pheochromocytoma
Scanner: Symbia Intevo Bold
Data courtesy of University Hospital of Würzburg, Würzburg, Germany.

xSPECT Bone sharply delineates bony remodeling and facet arthropathy
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Tift Regional Medical Center, Tifton, Georgia, USA.

xSPECT Bone sharply delineates bony remodeling and facet arthropathy
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

xSPECT Bone sharply defines cervical vertebreal instability
Scanner: Symbia Intevo BoldTM
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

xSPECT Bone sharply delineates severe osteoarthritis in the left hip joint
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

Reducing metal artifacts with iMAR may lead to more accurate quantification
Scanner: Symbia Intevo BoldTM SPECT/CT

Reducing image distortion with iMAR may improve accuracy of image interpretation
Scanner: Symbia Intevo BoldTM SPECT/CT

iMAR helps visualization of anatomical and functional findings in areas impacted by metal artifacts
Scanner: Symbia Intevo BoldTM SPECT/CT

xSPECT Quant enables quantification of tracer uptake to support therapy response assessment
Scanner: Symbia Intevo BoldTM SPECT/CT

Quantification of therapeutic dose in metastatic lesions with 177Lu PSMA
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of University Hospital of Würzburg, Würzburg, Germany.

xSPECT Quant used in 123I MIBG study to accurately evaluate uptake in suspected pheochromocytoma
Scanner: Symbia Intevo Bold
Data courtesy of University Hospital of Würzburg, Würzburg, Germany.

xSPECT Bone sharply delineates bony remodeling and facet arthropathy
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Tift Regional Medical Center, Tifton, Georgia, USA.

xSPECT Bone sharply delineates bony remodeling and facet arthropathy
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

xSPECT Bone sharply defines cervical vertebreal instability
Scanner: Symbia Intevo BoldTM
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.

xSPECT Bone sharply delineates severe osteoarthritis in the left hip joint
Scanner: Symbia Intevo BoldTM SPECT/CT
Data courtesy of Carilion Roanoke Memorial, Roanoke, VA, USA.










Technical Specifications
Gantry |
|
Tunnel opening | 70 cm |
Tunnel length | 89 cm |
CT |
|
Generator power | 50 kW |
Rotation time | up to 0.5 s |
Tube voltage | 80, 110, 130 kv |
Iterative reconstruction | SAFIRE3, 4 |
Metal artifact reduction | iMAR2, 4 |
Slices | 16/321 |
SPECT |
|
Crystal thickness | 3/8” or 5/8” |
Detector dimension (FOV) | 53.3 x 38.7 cm |
Energy range | 35-588 keV |
System Sensitivity (LEHR at 10 cm) | 202 cpm/μCi |
Acquisition modes | Static, dynamic, gated, SPECT, gated SPECT, dynamic SPECT, whole-body, whole-body SPECT, SPECT/CT, xSPECT™ |
Quantitative accuracy | ≤ 5%4, 5 |
Attenzione: Siemens Healthineers è consapevole che misuratori di glucosio non invasivi e ad uso domestico sono offerti in vendita su numerosi siti e social network. Questi prodotti non sono sviluppati né prodotti né distribuiti da Siemens Healthineers. Chi promuove e distribuisce tali prodotti, che non provengono, né sono riferibili o autorizzati da Siemens Healthineers, sta utilizzando impropriamente ed illegalmente il brand dell’azienda. Se vi siete imbattuti in un annuncio o in una pagina web di questo tipo, segnalateci i dettagli via e-mail a: healthcare.it.communications.rc-it.team@siemens-healthineers.com
Avvertenza: Accesso al sito siemens-healthineers.com/it
Le informazioni contenute in questo sito sono destinate in via esclusiva agli operatori professionali della sanità in conformità all’art. 21 del D.Lgs. 24 febbraio 1997, n. 46 s.m.i e alle Linee Guida del Ministero della Salute del 17 febbraio 2010 e successivo aggiornamento del 18 marzo 2013.
Per proseguire cliccare ’OK’ per uscire cliccare ’Annulla’.
Il sistema ricorderà la vostra scelta.